A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax(®)) in patients with peritoneal malignancies

por Williamson, Stephen K., Johnson, Gary A., Maulhardt, Holly A., Moore, Kathleen M., McMeekin, D. S., Schulz, Thomas K., Reed, Gregory A., Roby, Katherine F., Mackay, Christine B., Smith, Holly J., Weir, Scott J., Wick, Jo A., Markman, Maurie, diZerega, Gere S., Baltezor, Michael J., Espinosa, Jahna, Decedue, Charles J.
Publicado en Cancer Chemother Pharmacol (2015)